Introduction
recognized and described the pathophysiology of Rh-haemolytic disease of the newborn and its relationship to maternal isoimmunization. It was not until the rediscovery of the anti-human globulin technique by Coombs et al. (1945) , however, that laboratories had a sufficiently sensitive serological test to detect incomplete antibodies in the sera of immunized women. Since then, estimates of the overall incidence of maternal Rh immunization have varied from 2 5 to 10% (Clemens and Walsh, 1954; Allen and Diamond, 1958 ; Nevanlinna and Vainio, 1962 ; Worlledge et al., 1968) of the women at risk. These studies, however, do not allow one to determine the risk of maternal Rh immunization-after a single Rh-incompatible pregnancy.
In the prospective studies on the prevention of maternal Rh immunization with Rh-immune globulin reported from the United States (Ascari et al., 1968 ; Pollack et al., 1968a) , Canada (Zipursky, 1968) , Liverpool (Finn, 1968) , and Freiberg (J. Schneider, personal communication, 1968 ) the incidence of Rh immunization in the unprotected control groups as determined by the presence of detectable anti-Rh in their sera six months or longer post partum varied from 4 to 11 2%. In these studies only ABO compatible mother-infant pairs were followed, and in the Liverpool study the parturient women were also required to manifest evidence of foetal-maternal haemorrhages in excess of 0-25 ml. as determined by the KleihauerBethke technique.
In our prospective observations of over 2,800 Rh-negative women having one or more Rh-positive infants, we 
Results
A total of 2,876 mother-infant pairs were admitted to the Rh-immune globulin trials for their first observed pregnancies and followed for a minimum of six months post partum. Of the 1,834 treated patients, 300 received the large dose (4,000-6,000 leg.) of Rh-immune globulin and 1,534 received the smaller dose (not less than 300 /ug.). The incidence of maternal Rh immunization as determined by the presence of anti-Rh in the maternal sera six months post partum is shown in Table I .
Two of the 1,834 (0 1 %0) treated patients were actively immunized despite passive immunization within 72 hours post partum; whereas in the control series 73 of 1,042 (70 0) were found to have circulating Rh antibodies. (Billingham, 1964 post-partum period, and that Rh antibodies may escape detection until a subsequent stimulation by another Rh-positive pregnancy. It would appear therefore that the incidence of maternal Rh immunization after a single Rh-positive ABO compatible pregnancy is about 17%. Those examples of Rh immunization which have been reported to occur intra partum in all probability result from previous Rh-positive pregnancies or other exposure to the Rh antigen. Even in a group of Rh-negative primiparae one must be circumspect in ruling out the possibility of previous exposure to the Rh antigen because of: (1) a previously unsuspected Rh-positive pregnancy terminating in abortion; (2) previous transfusion of Rh-positive whole blood; (3) the injection of Rh-negative female infants with whole blood for the prevention of haemorrhagic disease of the newborn before the discovery of vitamin K; and (4) the intramuscular injection of whole blood for measles prophylaxis. While all of these practices have been abandoned as dangerous, a legacy of Atrogenically immunized Rh-negative women may still become apparent after subimmunizing doses of Rh antigen during pregnancy many years later.
In the Rh-immune globulin studies reported here, only ABO compatible mother-infant pairs were examined. Whereas there is wide agreement that the coexistence of ABO and Rh incompatibility between mother and child decreases the incidence of maternal Rh immunization, the extent of this decrease is disputed. Numerous investigators (Van Loghem and Spaander, 1948; Wiener et al., 1949; Donohue et al., 1954; Reepmaker, 1955 ; Heistd, 1955) have confirmed Levine's (1943) early observation that fewer infants with Rh-haemolytic disease were born to mothers who were ABO incompatibly mated than expected. These observations, while valid, cannot be used to assign the degree of protection against maternal Rh immunization, since (1) the incidence of Rh-haemolytic disease is not equal to the incidence of maternal Rh immunization, and (2) cases of Rh-haemolytic disease tend to be less severe where dual (ABO and Rh) incompatibility exists between mother and infant. Hence, some of the latter cases of Rh-haemolytic disease may escape the attention of specialty clinics where severe cases are referred.
Expected and Observed Incidence
In three large independent studies Reepmaker (1955) , Cohen (1960) , and Donohue and Wake (1964) have reported the ABO blood group of Rh-immunized women and their husbands. In all three studies summarized in Table III , it may be seen that there was no statistical difference between the expected and observed incidence of Rh-immunized women mated A xB, B x A, AB x A or B, except for the minimal significance seen in the A x B matings in Reepmaker's study. There was, however, a 31-49% decrease from the expected incidence of Rh immunization in the group 0 women in the matings A x 0 and B x O. The decrease in incidence of Rh immunization in the group 0 mothers and the absence of protection in the non-group 0 mothers may be due to the qualitative difference in the anti-A and anti-B isoagglutinins of the two groups, as has been shown by Rawson and Abelson (1960) . The predominantly 7S anti-A and anti-B of group 0 women may be more effective in preventing ABO and Rh-incompatible foetal erythrocytes from gaining access to the maternal immune system.
If the incidence of Rh immunization after a single ABO compatible, Rh-incompatible pregnancy is about 17%, as is suggested by the present study, then the incidence of maternal Rh immunization for group 0 and non-group O women with ABO incompatibility is 9-12% and 17% respectively.
The upward revision of probability of maternal Rh immunization is important to establish the risk of an unprotected Rh-incompatible pregnancy, since specific immunoprophylaxis is now widely available. These studies indicate that the overall incidence is more than twice that previously reported for ABO compatible and incompatible matings. The recognition of the time of immunization is significant inasmuch as it justifies the rationale for using passive immunization as a single post-partum injection rather than as an intrapartum measure, as has been proposed by Zipursky and Israels (1967) . In addition to the wasteful nature of treating Rh-negative women with a foetus of undetermined Rh type (12 of the 47 women treated intrapartum gave birth to Rh-negative infants), this practice suffers from one additional disadvantage. The Rh-positive infants born to Rhnegative women treated during the last trimester of pregnancy may have a positive direct Coombs reaction, which, if not properly evaluated, could mask the coexistence of haemolytic disease due to blood group antibodies other than anti-Rh. The prognostic value of this useful procedure on the cord blood specimen is unnecessarily surrendered.
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